3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
71
Rectal Neoplasms
38
Pancreatic Neoplasms
32
Colonic Neoplasms
31
Neoplasms
29
Stomach Neoplasms
22
Neoplasm Metastasis
22
Carcinoma, Non-Small-Cell Lung
18
Esophageal Neoplasms
16
Unspecified Adult Solid Tumor, Protocol Specific
15
Head and Neck Neoplasms
13
Adenocarcinoma
11
Squamous Cell Carcinoma of Head and Neck
10
Breast Neoplasms
10
Ovarian Neoplasms
8
Lung Neoplasms
8
Lymphoma, Non-Hodgkin
6
Esophageal Squamous Cell Carcinoma
6
Carcinoma, Renal Cell
6
Solid Tumor
5
Lymphoma
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Gallbladder Neoplasms
5
Cholangiocarcinoma
5
Adenocarcinoma Of Esophagus
5
Triple Negative Breast Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Peritoneal Neoplasms
4
Melanoma
4
Liver Neoplasms
4
Interventions
Dexamethasone
2
vistusertib
1
ricolinostat
1
pomalidomide
1
irinotecan sucrosofate
1
idelalisib
1
daratumumab
1
bermekimab
1
atezolizumab
1
alovudine
1
TKM-080301
1
TIC10 compound
1
S-Adenosylmethionine
1
Prostatectomy
1
Pluvicto
1
MicroRNAs
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Ipilimumab
1
Ga(III)-DOTATOC
1
Fluorouracil
1
Cyclophosphamide
1
Blood Specimen Collection
1
(225)Ac-PSMA-617
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Disease
×
Fluorouracil
×
Clear all
NCT03207724
2020-12-30
OnFX
Cedars-Sinai Medical Center
Phase 1
Completed
16 enrolled